Olmesartan
is an Angiotensin 2 Receptor Blocker. The apparatus of activity of olmesartan
is as an Angiotensin 2 Receptor Antagonist.
Olmesartan
about is able-bodied tolerated. In analytic trials, blackout occurred in 2.8
percent of olmesartan-treated patients and in 0.9 percent of placebo-treated
patients. In a abstraction comparing olmesartan to added ARBs, the accident of
blackout was agnate in olmesartan (1.4 percent), losartan (Cozaar; 0.7
percent), valsartan (Diovan; 1.4 percent), and irbesartan (Avapro; 3.4
percent). Headache was appear by 1.3 percent of patients accepting olmesartan
and 2.5 percent accepting candesartan (Atacand).As with added ARBs, the
accident of ahem with olmesartan is commensurable to that with placebo (0.9 and
0.7 percent, respectively).
No comments:
Post a Comment